Despite the availability of tumor markers like carcinoembryonic antigen (CEA), CA19-9, CA72-4, CA125, and CA242 for gastric cancer diagnosis, their effectiveness in detecting early-stage disease remains limited, with early gastric cancer detection rates as low as 10%. This evidence concerns the gene CEACAM5 and gastric cancer.